Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-22
DOI
10.3389/fpsyt.2021.703452
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Revisiting pharmacology of oxidative stress and endothelial dysfunction in cardiovascular disease: Evidence for redox-based therapies
- (2020) Andreas Daiber et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effects of inflammation on the kynurenine pathway in schizophrenia — a systematic review
- (2020) Bruno Pedraz-Petrozzi et al. Journal of Neuroinflammation
- Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits
- (2020) David R. Goldsmith et al. Frontiers in Psychiatry
- Role of oxidative stress in depression
- (2020) Shvetank Bhatt et al. DRUG DISCOVERY TODAY
- Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase
- (2020) Yi-Ling Chien et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Oxidative stress and diabetes: antioxidative strategies
- (2020) Pengju Zhang et al. Frontiers of Medicine
- Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach
- (2020) Michael Maes et al. MOLECULAR NEUROBIOLOGY
- Sex differences in the association between symptoms and superoxide dismutase in patients with never-treated first-episode schizophrenia
- (2020) Dong Mei Wang et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation
- (2020) Ashley L. Comer et al. Frontiers in Cellular Neuroscience
- Maternal Immune Activation and the Development of Dopaminergic Neurotransmission of the Offspring: Relevance for Schizophrenia and Other Psychoses
- (2020) Argel Aguilar-Valles et al. Frontiers in Psychiatry
- Neurodevelopmental insights into circuit dysconnectivity in schizophrenia
- (2020) Moushumi Nath et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects
- (2019) Antonio Rampino et al. Frontiers in Psychiatry
- Serotonin receptor HTR6-mediated mTORC1 signaling regulates dietary restriction–induced memory enhancement
- (2019) Ling-Ling Teng et al. PLOS BIOLOGY
- A Genetics Perspective on the Role of the (Neuro)Immune System in Schizophrenia
- (2019) Rebecca Birnbaum et al. SCHIZOPHRENIA RESEARCH
- The glutathione cycle shapes synaptic glutamate activity
- (2019) Thomas W. Sedlak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
- (2019) Chieh-Hsin Lin et al. Frontiers in Psychiatry
- A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia
- (2019) Dag K. Solberg et al. ACTA NEUROPSYCHIATRICA
- Role of magnetic resonance spectroscopy in cerebral glutathione quantification for youth mental health: A systematic review
- (2019) Emily Fisher et al. Early Intervention in Psychiatry
- Theoretical description of modern 1 H in Vivo magnetic resonance spectroscopic pulse sequences
- (2019) Karl Landheer et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study
- (2019) Deanna L. Kelly et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings
- (2019) Kenji Hashimoto Current Psychiatry Reports
- The Core Deficit of Classical Schizophrenia: Implications for Predicting the Functional Outcome of Psychotic Illness and Developing Effective Treatments
- (2019) Peter F. Liddle CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- The origin of NMDA receptor hypofunction in schizophrenia
- (2019) Kazu Nakazawa et al. PHARMACOLOGY & THERAPEUTICS
- Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia
- (2019) Caitlin OB Yolland et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- N -acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials
- (2018) W. Zheng et al. ACTA PSYCHIATRICA SCANDINAVICA
- Endogenous non-enzymatic antioxidants in the human body
- (2018) Iwona Mirończuk-Chodakowska et al. Advances in Medical Sciences
- Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: A systematic review and meta-analysis
- (2018) Padraig Oakley et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Glutathione and glutamate in schizophrenia: a 7T MRS study
- (2018) Jyothika Kumar et al. MOLECULAR PSYCHIATRY
- Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism
- (2018) João M. N. Duarte et al. NEUROCHEMICAL RESEARCH
- Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway
- (2018) Inés Ibarra-Lecue et al. NEUROPSYCHOPHARMACOLOGY
- Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses
- (2018) Berta Moreno-Küstner et al. PLoS One
- Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations
- (2018) Norbert Müller SCHIZOPHRENIA BULLETIN
- Psychiatric risk gene Cacna1c determines mitochondrial resilience against oxidative stress in neurons
- (2018) Susanne Michels et al. Cell Death & Disease
- Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation
- (2018) Akiko Matsuura et al. Scientific Reports
- mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders
- (2018) Larisa Ryskalin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis
- (2018) David Fraguas et al. SCHIZOPHRENIA BULLETIN
- Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?
- (2018) Rita Khoury et al. SCHIZOPHRENIA RESEARCH
- Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia
- (2018) Zhi-Le Bai et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Diet and Psychosis: A Scoping Review
- (2018) Monique Aucoin et al. NEUROPSYCHOBIOLOGY
- Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients
- (2018) Huimei An et al. Translational Psychiatry
- Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases
- (2018) Bee Ling Tan et al. Frontiers in Pharmacology
- Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk
- (2017) Henry Barron et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Predictive value of selected biomarkers related to metabolism and oxidative stress in children with autism spectrum disorder
- (2017) Afaf El-Ansary et al. METABOLIC BRAIN DISEASE
- Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia
- (2017) P Steullet et al. MOLECULAR PSYCHIATRY
- Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group
- (2017) S Kelly et al. MOLECULAR PSYCHIATRY
- The complement system: a gateway to gene–environment interactions in schizophrenia pathogenesis
- (2017) V L Nimgaonkar et al. MOLECULAR PSYCHIATRY
- Oxidative Stress: Harms and Benefits for Human Health
- (2017) Gabriele Pizzino et al. Oxidative Medicine and Cellular Longevity
- Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia
- (2017) Sumedha Mitra et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Neurocognitive effects of an omega-3 fatty acid and vitamins E+C in schizophrenia: A randomised controlled trial
- (2017) H. Bentsen et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
- (2017) Philippe Conus et al. SCHIZOPHRENIA BULLETIN
- Age-related changes of superoxide dismutase activity in patients with schizophrenia
- (2017) Vladimir Djordjevic et al. Vojnosanitetski Pregled
- Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders
- (2017) Patrick D. McGorry et al. JAMA Psychiatry
- Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia
- (2017) D A Maas et al. Translational Psychiatry
- Functional Connectivity of Cognitive Brain Networks in Schizophrenia during a Working Memory Task
- (2017) Douglass Godwin et al. Frontiers in Psychiatry
- Risk-Conferring Glutamatergic Genes and Brain Glutamate Plus Glutamine in Schizophrenia
- (2017) Juan R. Bustillo et al. Frontiers in Psychiatry
- Oxidative metabolism may be associated with negative symptoms in schizophrenia
- (2017) Mehmet Gunes et al. Psychiatry and Clinical Psychopharmacology
- Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study
- (2016) Dag K. Solberg et al. BMC Psychiatry
- Microglial activation and progressive brain changes in schizophrenia
- (2016) L E Laskaris et al. BRITISH JOURNAL OF PHARMACOLOGY
- Modular-level alterations of structure-function coupling in schizophrenia connectome
- (2016) Yu Sun et al. HUMAN BRAIN MAPPING
- A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia
- (2016) Tomasz Pawełczyk et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Iron chelation in the treatment of neurodegenerative diseases
- (2016) Petr Dusek et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Schizophrenia risk from complex variation of complement component 4
- (2016) Aswin Sekar et al. NATURE
- Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
- (2016) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- Epigenetic Basis of Mental Illness
- (2016) Eric J. Nestler et al. NEUROSCIENTIST
- Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis
- (2016) Lijing Xin et al. SCHIZOPHRENIA BULLETIN
- Neuroanatomical Predictors of Functional Outcome in Individuals at Ultra-High Risk for Psychosis
- (2016) Renate L. E. P. Reniers et al. SCHIZOPHRENIA BULLETIN
- Implications for reactive oxygen species in schizophrenia pathogenesis
- (2016) Minori Koga et al. SCHIZOPHRENIA RESEARCH
- Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology?
- (2016) P. Steullet et al. SCHIZOPHRENIA RESEARCH
- History of the Concept of Disconnectivity in Schizophrenia
- (2016) Joseph T. Coyle et al. HARVARD REVIEW OF PSYCHIATRY
- Antipsychotic medication in schizophrenia: a review
- (2015) John Lally et al. BRITISH MEDICAL BULLETIN
- Glutamate and dopamine in schizophrenia: An update for the 21st century
- (2015) Oliver Howes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α
- (2015) D Baumeister et al. MOLECULAR PSYCHIATRY
- White matter integrity and cognitive performance in school-age children: A population-based neuroimaging study
- (2015) Ryan L. Muetzel et al. NEUROIMAGE
- Antipsychotics and Amotivation
- (2015) Gagan Fervaha et al. NEUROPSYCHOPHARMACOLOGY
- First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment
- (2015) Asli Sarandol et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Analysis of oxidative stress expressed by urinary level of biopyrrins and 8-hydroxydeoxyguanosine in patients with chronic schizophrenia
- (2015) Tsuyoshi Miyaoka et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia
- (2015) Kim Q. Do et al. SCHIZOPHRENIA BULLETIN
- Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
- (2015) Valeria Mondelli et al. SCHIZOPHRENIA BULLETIN
- Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system
- (2015) Paul S. Baxter et al. Nature Communications
- Prefrontal cortex and the dysconnectivity hypothesis of schizophrenia
- (2015) Yuan Zhou et al. Neuroscience Bulletin
- Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice
- (2015) Juanjuan Tang et al. Scientific Reports
- Identification of a Common Neurobiological Substrate for Mental Illness
- (2015) Madeleine Goodkind et al. JAMA Psychiatry
- An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia
- (2015) Akihiro Shiina et al. Clinical Psychopharmacology and Neuroscience
- Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition
- (2014) Cristina Gonzalez-Liencres et al. BMC Psychiatry
- Vitamin Supplementation in the Treatment of Schizophrenia
- (2014) Hannah E. Brown et al. CNS DRUGS
- Targeting of NMDA receptors in new treatments for schizophrenia
- (2014) Kenji Hashimoto EXPERT OPINION ON THERAPEUTIC TARGETS
- NADPH oxidase- and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: a bipartisan affair?
- (2014) Evan A. Bordt et al. FREE RADICAL BIOLOGY AND MEDICINE
- Detection of glutamate, glutamine, and glutathione by radiofrequency suppression and echo time optimization at 7 tesla
- (2014) Li An et al. MAGNETIC RESONANCE IN MEDICINE
- Repeated Exposure of Adult Rats to Transient Oxidative Stress Induces Various Long-Lasting Alterations in Cognitive and Behavioral Functions
- (2014) Yoshio Iguchi et al. PLoS One
- Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis
- (2014) Rachel Upthegrove et al. SCHIZOPHRENIA RESEARCH
- Generation of superoxide anion radicals and platelet glutathione peroxidase activity in patients with schizophrenia
- (2014) Anna Dietrich-Muszalska et al. Neuropsychiatric Disease and Treatment
- Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life
- (2014) Golam M. Khandaker et al. JAMA Psychiatry
- 48 echo T2 myelin imaging of white matter in first-episode schizophrenia: Evidence for aberrant myelination
- (2014) Donna J.M. Lang et al. NeuroImage-Clinical
- Disruption of structure–function coupling in the schizophrenia connectome
- (2014) Luca Cocchi et al. NeuroImage-Clinical
- The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue
- (2014) Ralf Brisch et al. Frontiers in Psychiatry
- The role of oxidative stress during inflammatory processes
- (2013) Jérôme Lugrin et al. BIOLOGICAL CHEMISTRY
- Meta-Analysis of Oxidative Stress in Schizophrenia
- (2013) Joshua Flatow et al. BIOLOGICAL PSYCHIATRY
- N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
- (2013) Mehdi Farokhnia et al. CLINICAL NEUROPHARMACOLOGY
- Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia
- (2013) Alejandro Ballesteros et al. CLINICAL NEUROPHYSIOLOGY
- A mitochondrial bioenergetic etiology of disease
- (2013) Douglas C. Wallace JOURNAL OF CLINICAL INVESTIGATION
- Is the mTOR-signalling cascade disrupted in Schizophrenia?
- (2013) Anand Gururajan et al. JOURNAL OF NEUROCHEMISTRY
- Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
- (2013) LANCET
- Alterations of Superficial White Matter in Schizophrenia and Relationship to Cognitive Performance
- (2013) Arash Nazeri et al. NEUROPSYCHOPHARMACOLOGY
- Altered Interhemispheric and Temporal Lobe White Matter Microstructural Organization in Severe Chronic Schizophrenia
- (2013) Laurena Holleran et al. NEUROPSYCHOPHARMACOLOGY
- Inflammation and the two-hit hypothesis of schizophrenia
- (2013) Keith A. Feigenson et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- White matter deficits in first episode schizophrenia: An activation likelihood estimation meta-analysis
- (2013) Li Yao et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Changes in oxidative stress markers in patients with schizophrenia: The effect of antipsychotic drugs
- (2013) Meng-Chang Tsai et al. PSYCHIATRY RESEARCH
- Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: Reversal by clozapine
- (2013) Bruna Mara Machado Ribeiro et al. SCHIZOPHRENIA RESEARCH
- Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells
- (2013) Atsushi Sato et al. Stem Cell Research
- NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
- (2013) Melissa A. Snyder et al. Frontiers in Cellular Neuroscience
- A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia
- (2013) H Bentsen et al. Translational Psychiatry
- Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine
- (2012) Marisa Möller et al. BRAIN BEHAVIOR AND IMMUNITY
- 5-HT6receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia
- (2012) Julie Meffre et al. EMBO Molecular Medicine
- l-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells
- (2012) Branden J. Stansley et al. NEUROPHARMACOLOGY
- The role of gray and white matter segmentation in quantitative proton MR spectroscopic imaging
- (2012) Assaf Tal et al. NMR IN BIOMEDICINE
- Capturing the Angel in "Angel Dust": Twenty Years of Translational Neuroscience Studies of NMDA Receptor Antagonists in Animals and Humans
- (2012) B. Moghaddam et al. SCHIZOPHRENIA BULLETIN
- Oxidative Stress and Antioxidant Defense
- (2012) Esra Birben et al. World Allergy Organization Journal
- Behavioral phenotyping of glutathione-deficient mice: Relevance to schizophrenia and bipolar disorder
- (2011) Anita Kulak et al. BEHAVIOURAL BRAIN RESEARCH
- Bimodal Distribution of Polyunsaturated Fatty Acids in Schizophrenia Suggests Two Endophenotypes of the Disorder
- (2011) Håvard Bentsen et al. BIOLOGICAL PSYCHIATRY
- N-Acetylcysteine Normalizes Neurochemical Changes in the Glutathione-Deficient Schizophrenia Mouse Model During Development
- (2011) Joao Miguel das Neves Duarte et al. BIOLOGICAL PSYCHIATRY
- Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients
- (2011) Monia Raffa et al. BMC Psychiatry
- Animal models of schizophrenia
- (2011) CA Jones et al. BRITISH JOURNAL OF PHARMACOLOGY
- Oxidative Stress in Schizophrenia
- (2011) Iztok Grabnar et al. Current Neuropharmacology
- Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation
- (2011) Karina S. MacDowell et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- N-acetyl Cysteine Treatment Rescues Cognitive Deficits Induced by Mitochondrial Dysfunction in G72/G30 Transgenic Mice
- (2011) David-Marian Otte et al. NEUROPSYCHOPHARMACOLOGY
- Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia
- (2011) Xue Feng Li et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Elevated plasma superoxide dismutase in first-episode and drug naive patients with schizophrenia: Inverse association with positive symptoms
- (2011) Zhiwei Wu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
- (2010) Alan S. Brown et al. AMERICAN JOURNAL OF PSYCHIATRY
- Genetic Association Studies of Antioxidant Pathway Genes and Schizophrenia
- (2010) Kodavali V. Chowdari et al. ANTIOXIDANTS & REDOX SIGNALING
- Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
- (2010) Jeffrey K. Yao et al. ANTIOXIDANTS & REDOX SIGNALING
- Isolation rearing-induced deficits in sensorimotor gating and social interaction in rats are related to cortico-striatal oxidative stress, and reversed by sub-chronic clozapine administration
- (2010) Marisa Möller et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders
- (2010) Jeremy W. Gawryluk et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Dysconnectivity in schizophrenia: Where are we now?
- (2010) William Pettersson-Yeo et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Oxidative stress in schizophrenia: An integrated approach
- (2010) Byron K.Y. Bitanihirwe et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Genetic polymorphisms of glutathione S-transferases GSTM1, GSTT1, GSTP1 and GSTA1 as risk factors for schizophrenia
- (2010) Paolo Gravina et al. PSYCHIATRY RESEARCH
- Baseline and Amphetamine-Stimulated Dopamine Activity Are Related in Drug-Naïve Schizophrenic Subjects
- (2009) Anissa Abi-Dargham et al. BIOLOGICAL PSYCHIATRY
- Antioxidant Activity of Sulfur and Selenium: A Review of Reactive Oxygen Species Scavenging, Glutathione Peroxidase, and Metal-Binding Antioxidant Mechanisms
- (2009) Erin E. Battin et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Single-Electron Transfer and Single-Electron Transfer Degenerative Chain Transfer Living Radical Polymerization
- (2009) Brad M. Rosen et al. CHEMICAL REVIEWS
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
- MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis
- (2009) Radhika Srinivasan et al. MAGNETIC RESONANCE IMAGING
- Changes in erythrocyte membrane fatty acids during a clinical trial of eicosapentaenoic acid (EPA) supplementation in schizophrenia
- (2009) Susan J. van Rensburg et al. METABOLIC BRAIN DISEASE
- Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
- (2009) Shaun M. Purcell et al. NATURE
- White-matter markers for psychosis in a prospective ultra-high-risk cohort
- (2009) O. J. N. Bloemen et al. PSYCHOLOGICAL MEDICINE
- Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics
- (2009) Xiang Yang Zhang et al. PSYCHOPHARMACOLOGY
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Voxel-based morphometry in schizophrenia: implications for neurodevelopmental connectivity models, cognition and affect
- (2008) Leanne M Williams Expert Review of Neurotherapeutics
- LateN-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation
- (2008) Fabien Lanté et al. HIPPOCAMPUS
- PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice
- (2008) Leanne E Rivers et al. NATURE NEUROSCIENCE
- Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses
- (2008) Sofia Papadia et al. NATURE NEUROSCIENCE
- The Case for Autoimmunity in the Etiology of Schizophrenia
- (2008) Carroll-Ann W Goldsmith et al. PHARMACOTHERAPY
- Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T 1H-MRS Study
- (2008) Daisuke Matsuzawa et al. PLoS One
- Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS)
- (2008) Shin'Ya Tayoshi et al. SCHIZOPHRENIA RESEARCH
- Social functioning in individuals at clinical high risk for psychosis
- (2007) Jean Addington et al. SCHIZOPHRENIA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now